Royal London Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $64M | Sell |
|
|||||
|
2025
Q1 | $68.1M | Buy |
|
|||||
|
2024
Q4 | $65.3M | Buy |
|
|||||
|
2024
Q3 | $69.3M | Buy |
|
|||||
|
2024
Q2 | $65.2M | Sell |
|
|||||
|
2024
Q1 | $65.2M | Sell |
|
|||||
|
2023
Q4 | $67.7M | Buy |
|
|||||
|
2023
Q3 | $76.7M | Buy |
|
|||||
|
2023
Q2 | $80.7M | Buy |
|
|||||
|
2023
Q1 | $82.2M | Buy |
|
|||||
|
2022
Q4 | $102M | Buy |
|
|||||
|
2022
Q3 | $84.1M | Sell |
|
|||||
|
2022
Q2 | $104M | Buy |
|
|||||
|
2022
Q1 | $102M | Buy |
|
|||||
|
2021
Q4 | $112M | Sell |
|
|||||
|
2021
Q3 | $84.4M | Sell |
|
|||||
|
2021
Q2 | $78.9M | Sell |
|
|||||
|
2021
Q1 | $74.5M | Buy |
|
|||||
|
2020
Q4 | $74.7M | Sell |
|
|||||
|
2020
Q3 | $76.6M | Sell |
|
|||||
|
2020
Q2 | $69.4M | Sell |
|
|||||
|
2020
Q1 | $71.7M | Sell |
|
|||||
|
2019
Q4 | $86.1M | Buy |
|
|||||
|
2019
Q3 | $78.1M | Sell |
|
|||||
|
2019
Q2 | $96.9M | Sell |
|
|||||
|
2019
Q1 | $98.6M | Sell |
|
|||||
|
2018
Q4 | $107M | Buy |
|
|||||
|
2018
Q3 | $102M | Sell |
|
|||||
|
2018
Q2 | $89.1M | Buy |
|
|||||
|
2016
Q2 | $72.7M | Sell |
|
|||||
|
2016
Q1 | $1.47M | Buy |
|
|||||
|
2015
Q4 | $70.5M | Sell |
|
|||||
|
2015
Q3 | $68.2M | Buy |
|
|||||
|
2014
Q4 | $629K | Buy |
|
|||||
|
2014
Q3 | $46.6M | Buy |
|
|||||
|
2014
Q2 | $42M | Sell |
|
|||||
|
2014
Q1 | $43.5M | Sell |
|
|||||
|
2013
Q4 | $47.8M | Sell |
|
|||||
|
2013
Q3 | $48.2M | Sell |
|
|||||
|
2013
Q2 | $47.4M | Buy |
|